Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Analysis: Alimta patent seen as Lilly's "wild card"
Analysis: Alimta patent seen as Lilly's "wild card"
Analysis: Alimta patent seen as Lilly's "wild card"
Submitted by
admin
on January 4, 2013 - 10:05am
Source:
Yahoo/Reuters
News Tags:
Alimta
Eli Lilly
lung cancer
Headline:
Analysis: Alimta patent seen as Lilly's "wild card"
Do Not Allow Advertisers to Use My Personal information
